Successful treatment of interstitial lung disease in systemic lupus erythematosus with methotrexate.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8587090.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Corticosteroids are the accepted medical therapy of interstitial lung disease associated with systemic lupus erythematosus (SLE). We describe a case with a marked improvement in clinical status, pulmonary function testing and gallium lung scanning after treatment of interstitial pulmonary disease associated with SLE with weekly oral methotrexate alone.
Medical subject headings
- Immunosuppressive Agents
- Lung Diseases, Interstitial
- Lupus Erythematosus, Systemic
- Methotrexate